J Vivancos Mora

Learn More
The vitamin K antagonists (VKA) available for stroke prevention in patients with atrial fibrillation have many drawbacks due to their difficult clinical use and high risk of bleeding. Currently, several drugs are being developed as possible substitutes for VKA that have many advantages such as the lack of monitoring requirement and scarce pharmacologic and(More)
Acute ischemic stroke is a true medical emergency, as early diagnosis and treatment is the only viable way to open the so-called "therapeutic window" and prevent devastating consequences. Although neurological complications are few at onset and in the early hours, they are potential causes of death and morbidity. The main cause of death in the acute phase(More)
  • 1